Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan · Delayed Price · Currency is TWD 52.60
+1.40 (2.73%)
At close: Oct 30, 2026
Pet Pharm Biotech Market Cap
Pet Pharm Biotech has a market cap or net worth of 3.06 billion as of October 30, 2026. It is the 25,691st most valuable company in the world and the 1,382nd biggest in Taiwan. Its market cap has decreased by 23.40% in one year.
Market Cap
3.06B
Enterprise Value
2.75B
Revenue
265.54M
Global Rank
Country Rank
#1,382 Taiwan
PE Ratio
102.11
ChartMarket Cap Chart
Since July 26, 2024, Pet Pharm Biotech's market cap has increased from 1.39B to 3.06B, an increase of 119.48%. That is a compound annual growth rate of 41.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 3.06B | -14.76% |
| Dec 31, 2025 | 3.58B | 116.51% |
| Dec 31, 2024 | 1.66B | 18.92% |
| Jul 26, 2024 | 1.39B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 19.32B |
| Elixiron Immunotherapeutics (Cayman) Limited | 16.31B |
| Obigen Pharma | 7.20B |
| Intelligene | 7.05B |
| Uwell Biopharma | 5.77B |
| Tripartite Therapeutics | 4.64B |
| BIONET Therapeutics | 2.52B |
| Genomics BioSci & Tech. | 1.21B |